CNBX - Cannabics Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue8/31/20188/31/20178/31/20168/31/2015
Total Revenue9.6015.684112.5-
Cost of Revenue----
Gross Profit9.6015.684112.5-
Operating Expenses
Research Development1,003.916246.943177.607139.438
Selling General and Administrative2,814.4131,612.639215.57397.062
Non Recurring----
Others----
Total Operating Expenses3,818.3291,859.582393.177536.5
Operating Income or Loss-3,808.728-1,853.898-280.677-536.5
Income from Continuing Operations
Total Other Income/Expenses Net32.111-79.943-26.504-4.887
Earnings Before Interest and Taxes-3,808.728-1,853.898-280.677-536.5
Interest Expense---27.178-3.026
Income Before Tax-3,776.617-1,933.841-307.181-541.387
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-3,776.617-1,933.841-307.181-541.387
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,776.617-1,933.841-307.181-541.387
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-3,776.617-1,933.841-307.181-541.387